Using registry data to identify gaps in research and enhance our clinical trial activity
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Cancer Council Australia, Sydney, NSW.
Correspondence: ian.olver@cancer.org.au
- 1. Dear RF, Barratt AL, McGeechan K, et al. Landscape of cancer clinical trials in Australia: using trial registries to guide future research. Med J Aust 2011; 194: 387-391. <MJA full text>
- 2. MacKenzie R, Chapman S, Johnson N, et al. The newsworthiness of cancer in Australian television news. Med J Aust 2008; 189: 155-158. <MJA full text>
- 3. Pharmaceuticals Industry Strategy Group. Final report December 2008. Canberra: Commonwealth of Australia, 2009.
- 4. Medicines Australia. How to save Australia’s declining clinical trials [media release]. 18 Feb 2011. http://medicinesaustralia.com.au/2011/02/18/how-to-save-australias-declining-clinical-trials (accessed Mar 2011).
- 5. Access Economics. Exceptional returns: the value of investing in health R&D in Australia II. Report prepared for Australian Society for Medical Research. Canberra: Access Economics, 2008.
- 6. Stead M, Cameron D, Lester N, et al. Strengthening clinical cancer research in the United Kingdom. Br J Cancer 2011; Mar 1. [Epub ahead of print.]
- 7. Béhier JM, Reynier JC, Bertoye PH, Vray M; participants of Round Table no2 of Giens XXV. Clinical trials and E-health: impact of new information technology applied to clinical trials (including source data-medical records) and to human and drug research. Therapie 2010; 65: 317-322.
- 8. Boult M, Fitzpatrick K, Maddern G, Fitridge R. A guide to multi-centre ethics for surgical research in Australia and New Zealand. ANZ J Surg 2011; 81: 132-136.
Online responses are no longer available. Please refer to our instructions for authors page for more information.